My son Keaton reports: Oklahoma opioid trial has national implications

Scroll down to content

By Bobby Ross Jr.

My son Keaton is a general reporting intern for The Oklahoman.

I was excited to see his story on the national implications of an ongoing trial against opioid manufacturer Johnson & Johnson at the top of Sunday’s front page.

Keaton, a 22-year-old journalism major, will be a senior this fall at Oklahoma Christian University, where he will serve as editor-in-chief of the student newspaper The Talon.

%d bloggers like this: